search
Back to results

Novel Treatment for Port Wine Stain Birthmarks

Primary Purpose

Port-Wine Stain

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
Talaporfin sodium
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Port-Wine Stain focused on measuring Port Wine Stain Birthmarks

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Male/Female 18 years and older
  • Have Port Wine Stain Birthmarks non-facial

Exclusion Criteria:

  • Under 18 years of age
  • No Port Wine Stain Birthmarks
  • pregnant/breast feeding

Sites / Locations

  • Beckman Laser Institute

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Port Wine Stain Birthmarks

Arm Description

Combined Photodynamic/Pulsed Dye Laser Therapy/Talaporfin sodium

Outcomes

Primary Outcome Measures

Port wine stain blanching
The outcome measure will be PWS blanching as assessed by Diffuse Reflectance Imaging/Laser Speckle Imaging/Spatial Frequency Domain Imaging.

Secondary Outcome Measures

Full Information

First Posted
July 17, 2013
Last Updated
October 28, 2022
Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT01924273
Brief Title
Novel Treatment for Port Wine Stain Birthmarks
Official Title
Novel Treatment for Port Wine Stain Birthmarks
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
July 3, 2017 (Actual)
Study Completion Date
July 3, 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Port wine stains Birthmark are congenital, progressive vascular malformations of the skin that occur in approximately 0.7% of newborns. Approximately 1.5 million individuals in the United States and 32 million people worldwide have Port wine stains birthmarks. Two-thirds of these malformations occur on the face. Personality development of virtually all patients is adversely affected as a result of the negative reaction of others to a "marked" person. Detailed studies have documented lower self-esteem and difficulties with interpersonal interactions in Port wine stains patients. Port wine stains are initially flat and red, but with time, they tend to darken to purple and become thickened as vascular nodules develop. This thickening occurs in approximately two-thirds of lesions and further disfigures the facial features of many patients.
Detailed Description
Pulsed dye laser is currently the standard of care treatment for Port wine stains. Researchers at University of California Irvine at Beckman Laser Institute Medical Clinic can use Photodynamic therapy, another treatment option for Port wine stains. Photodynamic therapy involves light activation of a photosensitizer (a drug that is responsive to light or radiant energy). Because the photosensitizer can be localized to a desired portion of the Port wine stain, Photodynamic therapy creates an opportunity for targeted destruction of Port wine stains. Researchers will use a photosensitizer medication called Talaporfin sodium, an intravenously administered investigational photosensitizer, being evaluated for multiple clinical indications. Photodynamic therapy with talaporfin sodium has been investigated for many different conditions, and can be used for treatment for Port wine stains. Photosensitivity precaution instructions will be provided, including appropriate photo protective clothing, protective hat and sunglasses that wrap around the temples to help minimize lateral sun light exposure when traveling home following discharge from the study site. For efficacy, evaluated study variable will be Port wine stain blanching, and the researchers can use diffuse reflectance imaging chromametry, Laser Speckle Imaging and Spatial Frequency Domain Imaging to measure the change of Port wine stain blanching. The maximum power of the Laser Speckle Imaging and Spatial Frequency Domain Imaging light source is 10-50 mW, which is comparable to halogen-bulb household flashlights. Efficacy will be evaluated based on comparison of pre-treatment visit and post treatment day 1, week 1, week 4, and week 12 measurements.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Port-Wine Stain
Keywords
Port Wine Stain Birthmarks

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Port Wine Stain Birthmarks
Arm Type
Other
Arm Description
Combined Photodynamic/Pulsed Dye Laser Therapy/Talaporfin sodium
Intervention Type
Drug
Intervention Name(s)
Talaporfin sodium
Other Intervention Name(s)
Combined Laser treatment andTalaporfin sodium
Intervention Description
Combined Photodynamic/Pulsed Dye Laser Therapy/Talaporfin sodium
Primary Outcome Measure Information:
Title
Port wine stain blanching
Description
The outcome measure will be PWS blanching as assessed by Diffuse Reflectance Imaging/Laser Speckle Imaging/Spatial Frequency Domain Imaging.
Time Frame
up to 12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male/Female 18 years and older Have Port Wine Stain Birthmarks non-facial Exclusion Criteria: Under 18 years of age No Port Wine Stain Birthmarks pregnant/breast feeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kristen Kelly, MD
Organizational Affiliation
Beckman Laser Institute
Official's Role
Principal Investigator
Facility Information:
Facility Name
Beckman Laser Institute
City
Irvine
State/Province
California
ZIP/Postal Code
92612
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Novel Treatment for Port Wine Stain Birthmarks

We'll reach out to this number within 24 hrs